LifeTech Scientific (HKG:1302) attributable profit fell 16% to 222.4 million yuan in 2024 from 263.2 million yuan in 2023, according to a Friday filing with the Hong Kong bourse.
Earnings per share at the cardiovascular and peripheral vascular medical device manufacturer decreased to 0.051 yuan from 0.059 yuan in the previous year.
Revenue grew 2.9% to 1.31 billion yuan from 1.27 billion yuan a year earlier.